This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Falls Prevention Roadshow

CPNI has been made aware of an upcoming Falls Prevention event taking place on Wednesday 17th September 2025.  The event will take place in Ikea, Belfast between 11am and 2pm (drop-in).  The event is hosted by the Community Falls Prevention and Management Service and is open to patients, members of the public and healthcare staff.  Further information is available here.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The fifth update of concessionary prices were granted today for August 2025:
DrugPack
Size
Concessionary Price
Nefopam 30mg tablets90£4.09
Olanzapine 10mg tablets28£4.99
Olanzapine 2.5mg tablets28£3.51
Olanzapine 20mg tablets28£4.99
Olanzapine 7.5mg tablets28£1.25
Propranolol 80mg modified-release capsules28£5.94
Repaglinide 1mg tablets90£11.76

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The fourth update of concessionary prices were granted today for August 2025:
DrugPack
Size
Concessionary Price
Acetazolamide 250mg tablets112£51.02
Amiodarone 100mg tablets28£2.24
Amiodarone 200mg tablets28£4.82
Buprenorphine 2mg sublingual tablets sugar free7£1.83
Carbocisteine 250mg/5ml oral solution300£4.99
Co-amoxiclav 250mg/62mg/5ml oral suspension100£4.64
Erythromycin 250mg gastro-resistant tablets28£3.02
Exemestane 25mg tablets30£10.74
Febuxostat 80mg tablets28£5.07
Imipramine 10mg tablets28£2.49
Indapamide 2.5mg tablets28£6.11
Isosorbide mononitrate 40mg tablets56£4.65
Ivabradine 2.5mg tablets56£31.83
Lactulose 3.1-3.7g/5ml oral solution500£5.80
Letrozole 2.5mg tablets28£3.27
Levothyroxine sodium 12.5microgram tablets28£11.45
Lofepramine 70mg tablets56£24.27
Mefenamic acid 500mg tablets28£35.10
Midazolam 10mg/2ml solution for injection ampoules10£5.58
Naftidrofuryl 100mg capsules84£10.23
Nitrazepam 5mg tablets28£1.88
Nortriptyline 25mg tablets100£2.83
Nystatin 100,000units/ml oral suspension30£9.32
Oxytetracycline 250mg tablets28£10.50
Pioglitazone 30mg tablets28£4.99
Pioglitazone 45mg tablets28£24.62
Piroxicam 0.5% gel112£3.75
Pivmecillinam 200mg tablets10£7.78
Pregabalin 300mg tablets56£10.36
Prucalopride 2mg tablets28£8.91
Pyridostigmine bromide 60mg tablets200£16.28
Risperidone 500microgram tablets20£3.66
Rosuvastatin 15mg tablets28£3.54
Sitagliptin 100mg/5ml oral solution sugar free150£23.41
Trimethoprim 100mg tablets28£4.22
Trimethoprim 200mg tablets6£1.50
Trimethoprim 200mg tablets14£3.51
Venlafaxine 225mg modified-release capsules28£19.18
Water for injections 10ml ampoules10£2.57

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
CPNI has been made aware of a fully funded Level 2 Diploma in Pharmacy Services training programme which is open to eligible community pharmacy staff members in Northern Ireland.

SUMMARY

  • Further information on this fully funded training programme is available on the UCA website and the training provider website: Global Horizon Skills
  • The Level 2 Diploma in Pharmacy Services is supported by the Department for the Economy, meaning there is no cost incurred by the trainee or employer. 
  • Employers who enrol a staff member in the programme are provided with additional funding incentive of £670 per successful trainee. Further details are outlined in the programme flyer.
  • The programme booklet, with further details on the course criteria, delivery, content, and assessment is available here.
  • Enrolment for the Autumn intake will remain open until Friday 5th September 2025, with training due to commence on Wednesday 24th September 2025.
  • Queries and expressions of interest can be sent to catherine@ghskills.com or jade@ghskills.com.

ACTION

  • Contractors who wish to learn more about funded training opportunities for pharmacy staff can read the information linked above and share with relevant members of the pharmacy team.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The third update of concessionary prices were granted today for August 2025:
DrugPack SizeConcessionary Price
Betamethasone 500microgram soluble tablets sugar free100£31.95
Bumetanide 1mg tablets28£2.94
Buprenorphine 8mg sublingual tablets sugar free7£6.00
Co-codamol 30mg/500mg effervescent tablets32£2.40
Co-codamol 30mg/500mg effervescent tablets100£7.51
Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets84£34.13
Fenofibrate micronised 267mg capsules28£6.10
Fexofenadine 180mg tablets30£5.21
Fusidic acid 1% modified-release eye drops5£35.00
Methylphenidate 5mg tablets30£6.53
Morphine sulfate 10mg/1ml solution for injection ampoules10£4.53
Nabumetone 500mg tablets56£75.50
Nicotine 21mg/24hours transdermal patches7£10.05
Oxycodone 5mg/5ml oral solution sugar free250£8.89
Pregabalin 150mg tablets56£7.73
Pregabalin 50mg tablets84£5.51
Prochlorperazine 3mg buccal tablets50£17.68
Propantheline bromide 15mg tablets112£101.98

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor
SPPG have issued correspondence regarding the availability of antimicrobial agents used in tuberculosis (TB).

SUMMARY

The letter provides additional advice and guidance on the actions to take within general practices and community pharmacies to maintain essential patient access to treatment with anti-tuberculosis (TB) medicines.  The advice in this letter should be used in conjunction with the updated National Patient Safety Alert issued on 1 August 2025 until the supply disruptions are resolved.

ACTION

Community pharmacists should read the contents of the letter and share with relevant members of the community pharmacy team.

Any further updates will be shared as they become available.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive